Mesna - Generic Drug Details
✉ Email this page to a colleague
What are the generic sources for mesna and what is the scope of patent protection?
Mesna
is the generic ingredient in two branded drugs marketed by Fresenius Kabi Usa, Gland, Hikma, Mylan Institutional, Rising, Sagent Pharms Inc, Teva Pharms Usa, and Baxter Hlthcare, and is included in nine NDAs. Additional information is available in the individual branded drug profile pages.There are ten drug master file entries for mesna. Six suppliers are listed for this compound.
Summary for mesna
US Patents: | 0 |
Tradenames: | 2 |
Applicants: | 8 |
NDAs: | 9 |
Drug Master File Entries: | 10 |
Finished Product Suppliers / Packagers: | 6 |
Raw Ingredient (Bulk) Api Vendors: | 120 |
Patent Applications: | 2,468 |
Drug Prices: | Drug price trends for mesna |
What excipients (inactive ingredients) are in mesna? | mesna excipients list |
DailyMed Link: | mesna at DailyMed |
Pharmacology for mesna
Drug Class | Cytoprotective Agent |
Medical Subject Heading (MeSH) Categories for mesna
Anatomical Therapeutic Chemical (ATC) Classes for mesna
US Patents and Regulatory Information for mesna
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mylan Institutional | MESNA | mesna | INJECTABLE;INTRAVENOUS | 076488-001 | Mar 8, 2012 | DISCN | No | No | ⤷ Subscribe | ⤷ Subscribe | ⤷ Subscribe | ||||
Rising | MESNA | mesna | INJECTABLE;INTRAVENOUS | 203364-001 | Jul 18, 2014 | DISCN | No | No | ⤷ Subscribe | ⤷ Subscribe | ⤷ Subscribe | ||||
Fresenius Kabi Usa | MESNA | mesna | INJECTABLE;INTRAVENOUS | 075811-001 | Apr 26, 2001 | AP | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ⤷ Subscribe | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for mesna
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Baxter Hlthcare | MESNEX | mesna | INJECTABLE;INTRAVENOUS | 019884-001 | Dec 30, 1988 | 4,220,660 | ⤷ Subscribe |
Baxter Hlthcare | MESNEX | mesna | TABLET;ORAL | 020855-001 | Mar 21, 2002 | 5,262,169 | ⤷ Subscribe |
Baxter Hlthcare | MESNEX | mesna | TABLET;ORAL | 020855-001 | Mar 21, 2002 | 5,252,341 | ⤷ Subscribe |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Mesna Market Analysis and Financial Projection Experimental
More… ↓
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.